Ruthenium

Related publications (219)

Cobalt Redox Mediators for Ruthenium-Based Dye-Sensitized Solar Cells: A Combined Impedance Spectroscopy and Near-IR Transmittance Study

Michael Graetzel, Shaik Mohammed Zakeeruddin, Yuhang Liu

Dye-sensitized solar cells with power conversion efficiencies of up to 6.5% have been fabricated using a cobalt trisbipyridyl redox mediator with the cis-diisothiocyanato-(2,2'-bipyridyl-4,4'-dicarboxylic acid)-(2,2'-bipyridyl-4,4'-dinonyl) ruthenium(II) ( ...

American Chemical Society2011

, , ,

Two new heteroleptic ruthenium(II) photosensitizers that contains 2,2';6,2 ''-terpyridine with extended p-conjugation with donor groups, a 4,4'-dicarboxylic acid-2,2'-bipyridine anchoring ligand and a thiocyanate ligand have been designed, synthesized and ...

Royal Society of Chemistry2011

Quantification of platinum deposition in polymer electrolyte fuel cell membranes

Platinum catalyst dissolution with subsequent reduction and deposition of Pt particles in the membrane can lead to a significant loss of polymer electrolyte fuel cell (PEFC) performance. To quantify the amount of deposited platinum, a novel transmission el ...

2011

The present invention provides new bi-and polypyridine ligands of ruthenium dyes. The invention also provides solar cells, in particular dye-sensitized solar cells comprising the dyes. Formula (I): ...

2011

, ,

A new heteroleptic ruthenium complex, coded CYC-B12, incorporating an antenna ligand composed of sequential connections of a thienothiophene conjugated bridge and carbazole hole-transport moiety was prepared. This new sensitizer exhibits a lower energy MLC ...

American Chemical Society2011

A new catalytic procedure for atom-transfer radical addition (ATRA) and cyclization (ATRC) reactions is described. The combination of the ruthenium(III) complex [RuCl2Cp*(PPh3)] with magnesium allows these reactions to be performed under mild conditions wi ...

EPFL2010

In recent years, ruthenium-based antitumour drugs have emerged as an attractive alternative to cisplatin, exhibiting both excellent activity in tumours where cisplatin is of limited use and low general toxicity, leading to reduced side effects. Two rutheni ...

EPFL2010

Influence of water-soluble sulfonated phosphine ligands on ruthenium catalyzed generation of hydrogen from formic acid

Paul Joseph Dyson, Gabor Laurenczy, Céline Fellay, Weijia Gan

Hydrogen can be generated from formic acid in aq. phase homogeneous catalytic reactions using ruthenium catalysts with water-sol. phosphine ligands. A comparison of tri-, di-, and mono-sulfonato triphenylphosphine, disulfonato diphenyl-alkyl-phosphines (Ph ...

Taylor & Francis2010

Ruthenium-Catalyzed Hydrogenation of Bicarbonate in Water

Gabor Laurenczy, Matthias Beller

Hydrogenation of bicarbonates in water: By using a ruthenium-based catalytic system hydrogenation of sodium bicarbonate was achieved in water in comparable high TONs and yields. The hydrogenation of sodium bicarbonate takes place with the catalytic system ...

Wiley-VCH Verlag Berlin2010

Metabolization of [Ru(η6-C6H5CF3)(pta)Cl2]: a cytotoxic RAPTA-type complex with a strongly electron withdrawing arene ligand

Paul Joseph Dyson, Christian Hartinger, Anna Katherine Renfrew

The anticancer ruthenium-arene compd. [Ru(η6-C6H5CF3)(pta)Cl2] (pta = 1,3,5-triaza-7-phosphatricyclo[3.3.1.1]decane), termed RAPTA-CF3, with the electron-withdrawing α,α,α-trifluorotoluene ligand, is one of the most cytotoxic RAPTA compds. known. To ration ...

Springer-Verlag2010